Pharmacovigilance in Nutraceuticals and Dietary Supplements

  • Unique Paper ID: 192161
  • Volume: 12
  • Issue: 9
  • PageNo: 286-294
  • Abstract:
  • The concept of "Nutrivigilance," a synthesis of "nutrition" and "pharmaceutical," emphasizes the need for monitoring adverse drug reactions (ADRs) in nutraceuticals and dietary supplements. Defined by Dr. Stephen De Felice, Nutrivigilance involves systematic tracking, evaluation, and prevention of adverse effects, including interactions and safety concerns stemming from varying quality and regulatory oversight in nutraceutical products. With rising consumer reliance on these products, effective monitoring and reporting systems are critical to public health. Nutraceuticals, offering vital nutrients and therapeutic benefits, play a significant role in preventing or managing health conditions like obesity, diabetes, and heart diseases. The regulatory landscape varies globally, with structured systems in place for dietary supplements in the U. S. under the DSHEA and in the EU through various safety regulations. However, challenges remain, particularly in countries like India, where Nutrivigilance is still developing, lacking comprehensive post-market surveillance. The Pharmaco-vigilance Programme of India is in place to enhance drug safety monitoring, but further measures are needed to establish robust systems for nutraceuticals. The overall goal of these initiatives is to ensure public safety and confidence in the efficacy of nutraceutical products while facilitating research into their benefits and potential hazards.

Copyright & License

Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{192161,
        author = {Komal sanjay waykos and Payal Mudhe and Wilfred dsilva and Sandhya kamble and Kedar mane and Adnan Siddiqui},
        title = {Pharmacovigilance in Nutraceuticals and Dietary Supplements},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {9},
        pages = {286-294},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=192161},
        abstract = {The concept of "Nutrivigilance," a synthesis of "nutrition" and "pharmaceutical," emphasizes the need for monitoring adverse drug reactions (ADRs) in nutraceuticals and dietary supplements. Defined by Dr. Stephen De Felice, Nutrivigilance involves systematic tracking, evaluation, and prevention of adverse effects, including interactions and safety concerns stemming from varying quality and regulatory oversight in nutraceutical products. With rising consumer reliance on these products, effective monitoring and reporting systems are critical to public health. Nutraceuticals, offering vital nutrients and therapeutic benefits, play a significant role in preventing or managing health conditions like obesity, diabetes, and heart diseases. The regulatory landscape varies globally, with structured systems in place for dietary supplements in the U. S. under the DSHEA and in the EU through various safety regulations. However, challenges remain, particularly in countries like India, where Nutrivigilance is still developing, lacking comprehensive post-market surveillance. The Pharmaco-vigilance Programme of India is in place to enhance drug safety monitoring, but further measures are needed to establish robust systems for nutraceuticals. The overall goal of these initiatives is to ensure public safety and confidence in the efficacy of nutraceutical products while facilitating research into their benefits and potential hazards.},
        keywords = {Nutrivigilance, Nutraceuticals, ADRs, Safety, Surveillance, Regulation, Interactions, Quality, Public health.},
        month = {February},
        }

Cite This Article

  • ISSN: 2349-6002
  • Volume: 12
  • Issue: 9
  • PageNo: 286-294

Pharmacovigilance in Nutraceuticals and Dietary Supplements

Related Articles